Trevi Therapeutics Inc (TRVI)
2.65
-0.20
(-7.02%)
USD |
NASDAQ |
Apr 24, 16:00
2.67
+0.02
(+0.75%)
After-Hours: 20:00
Trevi Therapeutics Cash from Investing (TTM): 59.43M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 59.43M |
| September 30, 2023 | -1.723M |
| June 30, 2023 | -24.56M |
| March 31, 2023 | -98.41M |
| December 31, 2022 | -107.37M |
| September 30, 2022 | -59.07M |
| June 30, 2022 | -54.22M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 |
| Date | Value |
|---|---|
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -0.009M |
| September 30, 2019 | -0.101M |
| June 30, 2019 | -0.10M |
| March 31, 2019 | -0.11M |
| December 31, 2018 | -0.158M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-107.37M
Minimum
Dec 2022
59.43M
Maximum
Dec 2023
-26.01M
Average
-1.723M
Median
Sep 2023
Cash from Investing (TTM) Benchmarks
| Accuray Inc | -12.22M |
| Vanda Pharmaceuticals Inc | -12.06M |
| NovaBay Pharmaceuticals Inc | -0.019M |
| Palatin Technologies Inc | 9.293M |
| iBio Inc | 8.285M |